ACADIA PHARMACEUTICALS INC (ACAD:NASDAQ)
$26.22 -0.19 (-0.7194%)
Analysed ACADIA PHARMACEUTICALS INC (ACAD:NASDAQ) News Sources
The Surprising Reversal That Drove Acadia Pharma Closer To A Breakout
26-06-2026
yahoo.com
Strength Seen in Acadia (ACAD): Can Its 6.8% Jump Turn into More Strength?
29-06-2026
yahoo.com
ACAD Stock Up as CHMP Backs Daybu for EU Approval in Rett Syndrome
29-06-2026
yahoo.com
Acadia Pharmaceuticals Appoints Carl Segerstrom as Chief People Officer
06-07-2026
yahoo.com
RPRX or ACAD: Which Is the Better Value Stock Right Now?
09-07-2026
yahoo.com
Verastem (VSTM) Surges 6.3%: Is This an Indication of Further Gains?
10-07-2026
yahoo.com
How CHMP’s Positive Rett Syndrome Ruling on DAYBU Could Impact ACADIA Pharmaceuticals (ACAD) Investors
10-07-2026
yahoo.com
Is ACADIA Pharmaceuticals (ACAD) Still Undervalued After The Daybue Win?
10-07-2026
yahoo.com
ACADIA Pharmaceuticals (ACAD) Names A New Chief People Officer, Is It Still Below Fair Value?
11-07-2026
yahoo.com
An Acadia Pharmaceuticals Insider Sold Nearly Half Their Shares in the Company. What Does That Mean for Investors?
11-07-2026
fool.com
What is the current price of ACADIA PHARMACEUTICALS INC (ACAD:NASDAQ)?
The current price of ACADIA PHARMACEUTICALS INC (ACAD:NASDAQ) is $26.22.
ACADIA PHARMACEUTICALS INC (ACAD:NASDAQ) absolute price change since previous trading day?
The absolute price change of ACADIA PHARMACEUTICALS INC (ACAD:NASDAQ) since the previous trading day is $-0.19.
ACADIA PHARMACEUTICALS INC (ACAD:NASDAQ) percentage price change since previous trading day?
The percentage price change of ACADIA PHARMACEUTICALS INC (ACAD:NASDAQ) since the previous trading day is -0.7194%.
What is the most recent average sentiment score for ACADIA PHARMACEUTICALS INC (ACAD:NASDAQ)?
The most recent average sentiment score for ACADIA PHARMACEUTICALS INC (ACAD:NASDAQ) is 59 out of 100.
What is the most recent average sentiment for ACADIA PHARMACEUTICALS INC (ACAD:NASDAQ)?
The most recent sentiment for ACADIA PHARMACEUTICALS INC (ACAD:NASDAQ) is .
SEC-8K** Filing Available For ACADIA PHARMACEUTICALS INC (ACAD:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.